SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000920465-14-000021
Filing Date
2014-03-31
Accepted
2014-03-28 19:34:27
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ljpc-20131231x10k.htm 10-K 1134239
2 EXHIBIT ljpc-20131231xexhibit231.htm EX-23.1 3018
3 EXHIBIT ljpc-20131231xexhibit311.htm EX-31.1 14295
4 EXHIBIT ljpc-20131231xexhibit321.htm EX-32.1 8113
  Complete submission text file 0000920465-14-000021.txt   6272345

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ljpc-20131231.xml EX-101.INS 699209
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20131231.xsd EX-101.SCH 48131
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20131231_cal.xml EX-101.CAL 42692
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20131231_def.xml EX-101.DEF 233233
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20131231_lab.xml EX-101.LAB 587075
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20131231_pre.xml EX-101.PRE 351460
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36282 | Film No.: 14727404
SIC: 2836 Biological Products, (No Diagnostic Substances)